Physician

Ana Maria Crissien Martinez, M.D.

According to 2025 Medicare claims, Ana Martinez, M.D. (NPI: 1548563224) practices geriatric medicine in the San Diego-Chula Vista-Carlsbad, CA market, with the plurality of this provider's patient population coming from San Diego, CA. This provider's primary affiliated billing organization is SHARP REES-STEALY MEDICAL GROUP, INC (NPI: 1285616177; TIN: 330106028) and primary practice location at 92131-3940. Martinez is affiliated with the Sharp Rees-Stealy Medical Group (ACO ID: A5521), participating under the MSSP model.

Martinez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 148 traditional Medicare patients, billed 1,078 HCPCS/CPT codes, and received $56,163 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 521 prescription claims across 169 beneficiaries totaling $338,917 in drug costs, led by Vemlidy (Tenofovir Alafenamide). Open Payments data shows 2 records totaling $265. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $12,173 and ending at $56,163. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,529 to $338,917. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	37	185	$12,173
2017	136	1,039	$50,661
2018	126	911	$48,231
2019	168	1,441	$64,007
2020	122	815	$39,513
2021	145	1,163	$61,113
2022	120	919	$44,039
2023	127	887	$43,195
2024	148	1,078	$56,163

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	19	37	$5,529
2016	28	57	$8,125
2017	66	154	$159,843
2018	104	274	$164,348
2019	131	355	$154,382
2020	173	478	$143,543
2021	166	529	$86,450
2022	144	499	$120,911
2023	165	556	$259,712
2024	169	521	$338,917

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	40	40	$419
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	88	91	$56
99153	Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes	80	132	$11
J3010	Injection, fentanyl citrate, 0.1 mg	76	85	$1
J2250	Injection, midazolam hydrochloride, per 1 mg	83	491	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vemlidy	Tenofovir Alafenamide	11	330	$14,624
Ursodiol	Ursodiol	43	2,694	$8,595
Tenofovir Disoproxil Fumarate	Tenofovir Disoproxil Fumarate	11	630	$6,209
Dexlansoprazole Dr	Dexlansoprazole	11	990	$4,192
Omeprazole	Omeprazole	126	9,150	$2,943

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$265	Olympus America Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ana Maria Crissien Martinez, M.D.?

Tedicare shows public-source Medicare data for Ana Maria Crissien Martinez, M.D. (NPI 1548563224), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ana Maria Crissien Martinez, M.D. have ACO affiliation data?

Ana Maria Crissien Martinez, M.D. is shown with ACO affiliation data for Sharp Rees-Stealy Medical Group (MSSP, ACO ID A5521).

What billing organization is linked to Ana Maria Crissien Martinez, M.D.?

Ana Maria Crissien Martinez, M.D. is linked to SHARP REES-STEALY MEDICAL GROUP, INC (billing NPI 1285616177) in the available physician profile data.

Does Ana Maria Crissien Martinez, M.D. have Open Payments data?

Ana Maria Crissien Martinez, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.